Isigaba esitsha kuVango lweKlinikhi ye-Knee Osteoarthritis kulo lonke elase-US

A BAMBA isiKhululo sasimahla 5 | eTurboNews | eTN
Ibhalwe ngu Linda Hohnholz

IParadigm Biopharmaceuticals ibhengeza namhlanje ukuphehlelelwa ngokusemthethweni kwenkqubo yabo yovavanyo lweklinikhi yase-US kunye neqikelelo ye-56 ecwangcisiweyo yovavanyo lwendawo kwilizwe lonke ukuze kuqhutywe uvavanyo olubalulekileyo lwesigaba sesi-3 ukuxhasa ukubhaliswa kwePentosan Polysulfate Sodium (PPS) ye-osteoarthritis (OA) yedolo. . 

Eyasungulwa kwi-2014, i-Paradigm Biopharmaceuticals ichongiwe ngempumelelo, ibuyiselwe, kunye ne-PPS enelungelo lobunikazi, ekulawuleni intlungu kunye nokuvuvukala, okuhambelana nokuphazamiseka kwe-musculoskeletal okubandakanya i-osteoarthritis (phantsi kwe-trademark Zilosul®) kunye nesifo esinqabileyo se-mucopolysaccharidosis. 

IParadigm yandisa imisebenzi yayo yase-US ukuxhasa izifundo zobhaliso lwenkqubo ye-OA. Ngaxeshanye iParadigm ibhengeza ukuqaliswa kwesigaba se-3 senethiwekhi yovavanyo lwekliniki lweZilosul® ukunyanga i-knee osteoarthritis. Oku kubalulekile njengoko i-osteoarthritis iyona nto ibangela ukukhubazeka phakathi kwabantu abadala kwaye ichaphazela abantu abangaphezu kwezigidi ezingama-72 kulo lonke elase-US, eCanada, e-EU-5 nase-Australia.1,2

Injongo yolu phononongo kukulinganisa utshintsho kwiintlungu kunye nokusebenza ngeenaliti ezingaphantsi kwe-PPS xa kuthelekiswa nenaliti engaphantsi kwe-placebo kubathathi-nxaxheba abaneentlungu ze-kOA. Le yinqanaba le-2, i-adaptive, i-randomized, i-double-blind, i-placebo-controlled, i-multicenter (i-US / AUS / UK / EU) isifundo esiya kuvavanya umthamo kunye nomphumo wonyango we-PPS kubathathi-nxaxheba abaneentlungu ze-kOA.

Inqanaba le-1 libandakanya ukukhethwa kwe-dose ye-2b, kunye nabathathi-nxaxheba abafumana i-1 ye-3 ye-PPS i-dose regimens okanye i-placebo kwiiveki ze-6. Injongo ephambili yenqanaba le-1 kukukhetha umthamo wokusetyenziswa kwinqanaba le-2, idosi ekhethiweyo iya kusekelwe kwibhalansi efanelekileyo yokusebenza kunye nokhuseleko.

Abathathi-nxaxheba kwisigaba 1 baya kwabelwa ngokungacwangciswanga ukufumana:

• I-1.5 mg / kg ibalwe ubunzima bomzimba obufanelekileyo (IBW) PPS kabini ngeveki

• 2 mg/kg IBW PPS kanye ngeveki + placebo kanye ngeveki

• Idosi emiselweyo (100/150mg/180mg PPS ≤65/≥65 ukuya ≤90/>90 kg IBW) kanye ngeveki + i-placebo kanye ngeveki

• Placebo kabini ngeveki

Kwinqanaba lesi-2, abathathi-nxaxheba baya ku-1: 1 ukuba bafumane irejimeni yedosi ekhethiweyo ye-PPS okanye i-placebo kwiiveki ze-6.

Isiphelo esiphambili kwisifundo esibalulekileyo lutshintsho olusuka kwisiseko kwi-Day 56 kwintlungu ye-WOMAC® kunye neziphumo zesibini ezibandakanya utshintsho olusuka kwisiseko kumanqaku amaninzi ukuya kwi-168 kwi-WOMAC® Pain and Function, i-Palent Global Impression of Change and Quality of Life. .

"Ukuqaliswa kwenqanaba lesi-3 kulingo lwezonyango lwe-OA edolweni e-US kumele inyathelo elibalulekileyo ekukhuleni kweParadigm njengenkokeli yehlabathi ekubuyiseleni amachiza akhoyo." Uthi i-CEO yeThutyana, uGqr. Donna Skerrett. "Kukho idatha ekhuthazayo ebonisa ukuba i-PPS ayilonyango olusebenzayo kuphela ekulawuleni iintlungu, kodwa nakwisifo sokuguqula amandla, impumelelo ebalulekileyo yonyango engekhoyo kunyango lwe-osteoarthritis."

Ukwamkela indlela ekrelekrele kunye ne-agile kwi-R&D yeklinikhi, iqela elinamava leParadigm liye lakha kwaye lagcina intsebenziswano eyomeleleyo nenempumelelo kunye nabaphandi abaphambili beklinikhi kwintsimi. Ngokuphinda kusetyenziswe amachiza avunyiweyo e-FDA, iParadigm ijolise ekunciphiseni ixesha lomjikelo wophuhliso lwamachiza kwizicelo ezikhethiweyo kunye nokunciphisa iindleko zophuhliso. IParadigm isebenza ngekonsathi kunye, kwaye inezivumelwano zokubonelela ezikhethekileyo kunye, umnini kunye nomvelisi ovunyiweyo we-FDA we-PPS kuphela, bene-pharmaChem.3

UMlawuli woBudlelwane boMtyali-mali, uSimon White, ugxininise ukuba le "ndlela yokuthengisa inceda iindleko zeParadigm ekuphuhliseni iziyobisi kunye nokusebenzisa ugxininiso olongezelelweyo kunye nezibonelelo ekungqinelaniseni isicelo sechiza kwihlabathi jikelele, kunye nenkqubo yekliniki ejonge ukukhawulezisa ukuqaliswa kweZilosul e-US kunye nezinye. iimarike zehlabathi.”

INTO ONOKUYITHATHA KWELI NQAKU:

  • Isiphelo esiphambili kwisifundo esibalulekileyo lutshintsho olusuka kwisiseko kwi-Day 56 kwintlungu ye-WOMAC® kunye neziphumo zesibini ezibandakanya utshintsho olusuka kwisiseko kumanqaku amaninzi ukuya kwi-168 kwi-WOMAC® Pain and Function, i-Palent Global Impression of Change and Quality of Life. .
  • Injongo ephambili yenqanaba le-1 kukukhetha umthamo wokusetyenziswa kwinqanaba le-2, idosi ekhethiweyo iya kusekelwe kwibhalansi efanelekileyo yokusebenza kunye nokhuseleko.
  • UMlawuli woBudlelwane boMtyali-mali, uSimon White, ugxininise ukuba le "ndlela yokuthengisa inceda iindleko zeParadigm ekuphuhliseni ichiza kunye nokusebenzisa ugxininiso olongezelelweyo kunye nezibonelelo ekungqinelaniseni isicelo sechiza kwihlabathi jikelele, kunye nenkqubo yeklinikhi ejonge ukukhawulezisa ukuqaliswa kweZilosul kwi-U.

<

Malunga nombhali

Linda Hohnholz

Umhleli oyintloko we eTurboNews esekwe kwi-eTN HQ.

Bhlisa
Yaziswe ngawo
guest
0 izimvo
Inline feedbacks
Jonga zonke izimvo
0
Ndingazithanda iingcinga zakho, nceda uphawule.x
Yabelana ku...